Company Overview
Medi-Caps Limited operates in real estate sector in India. The company was incorporated in 1983 and is based in Indore, India.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.00.
Recent Developments
- Mar 2026 Revenue of ₹12.40 Cr (-51.1% YoY); net profit ₹-3.04 Cr.
- Trailing 12 Months Year-on-year growth — revenue +3.7%.
- 5-Year Trend Long-term compounding — revenue CAGR -36.6%, profit CAGR -91.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -36.57% |
| 1 Year: | 3.70% |
Compounded Profit Growth
| 5 Years: | -91.00% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -0.20% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -3.55% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- RSI (14)43.85 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -36.6% CAGR over 5 years.
- Earnings shrank at -91.0% CAGR over 5 years.
- Trading 29.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Real Estate).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MEDICAPQ Medi-Caps Limited NSE | 25.00 | -17.48 | ₹31.17 Cr | 0.00% | -9.95% | -2.72% | -36.57% | -91.00% |
| 2 | DLF DLF Limited NSE | 663.25 | 36.93 | ₹1.64 L Cr | 1.22% | 6.32% | 10.10% | 11.32% | 29.44% |
| 3 | LODHA Lodha Developers Limited NSE | 1,006.40 | 24.43 | ₹1.01 L Cr | 0.40% | 18.24% | 14.72% | 20.40% | 91.69% |
| 4 | PHOENIXLTD The Phoenix Mills Limited NIFTY_MIDNSE | 1,909.90 | 53.20 | ₹68,312.89 Cr | 0.14% | 11.84% | 11.14% | 19.36% | -2.86% |
| 5 | PRESTIGE Prestige Estates Projects Limited NIFTY_MIDNSE | 1,430.00 | 54.06 | ₹61,594.42 Cr | 0.14% | 12.48% | 7.75% | 15.15% | 8.28% |
| 6 | OBEROIRLTY Oberoi Realty Limited NIFTY_MIDNSE | 1,623.20 | 22.45 | ₹59,019.92 Cr | 0.46% | 16.71% | 13.99% | 12.92% | 9.60% |
| 7 | GODREJPROP Godrej Properties Limited NIFTY_MIDNSE | 1,565.00 | 29.46 | ₹47,141.95 Cr | 0.65% | 11.14% | 9.66% | 32.38% | 47.94% |
| 8 | BRIGADE Brigade Enterprises Limited NIFTY_SMALLNSE | 557.10 | 26.17 | ₹18,170.51 Cr | 0.37% | 9.78% | 9.45% | 18.55% | 30.28% |
| 9 | ANANTRAJ Anant Raj Limited NIFTY_SMALLNSE | 472.00 | 28.61 | ₹16,986.19 Cr | 0.16% | 10.39% | 9.62% | 37.94% | 54.47% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 6.94 Cr | 2.68 Cr | 2.01 Cr | 4.29 Cr | 3.42 Cr |
| Cost of Revenue | 2.78 Cr | 1.59 Cr | 61.10 L | 1.90 Cr | 1.54 Cr |
| Gross Profit | 4.16 Cr | 1.09 Cr | 1.39 Cr | 2.39 Cr | 1.88 Cr |
| Operating Expenses | 4.82 Cr | 4.90 Cr | 4.74 Cr | 3.89 Cr | 4.44 Cr |
| Operating Income | -66.53 L | -3.81 Cr | -3.35 Cr | -1.50 Cr | -2.56 Cr |
| EBITDA | 1.91 Cr | -3.04 Cr | -1.38 Cr | -30.05 L | 3.53 Cr |
| Interest Expense | 2.48 L | 1.30 L | 0 | 0 | 0 |
| Pretax Income | 1.45 Cr | -3.49 Cr | -1.82 Cr | -73.73 L | 3.03 Cr |
| Tax Provision | -27.01 L | 0 | 0 | 2.85 L | -1.44 L |
| Net Income | 1.72 Cr | -3.49 Cr | -1.82 Cr | -76.58 L | 3.04 Cr |
| Diluted EPS | - | - | - | - | - |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 48.58 Cr | 26.56 Cr | 25.37 Cr | 12.40 Cr |
| Cost of Revenue | - | 25.11 Cr | 9.52 Cr | 10.65 Cr | 5.64 Cr |
| Gross Profit | - | 23.47 Cr | 17.05 Cr | 14.72 Cr | 6.76 Cr |
| Operating Expenses | - | 20.65 Cr | 18.77 Cr | 18.27 Cr | 17.98 Cr |
| Operating Income | - | 2.81 Cr | -1.72 Cr | -3.55 Cr | -11.22 Cr |
| EBITDA | - | 6.73 Cr | 44.05 L | 90.19 L | -1.20 Cr |
| Interest Expense | - | 16,000 | 0 | 2.48 L | 1.30 L |
| Pretax Income | - | 4.92 Cr | -1.25 Cr | -84.11 L | -3.02 Cr |
| Tax Provision | - | 3.05 Cr | 99.47 L | -27.01 L | 1.41 L |
| Net Income | - | 1.76 Cr | -2.24 Cr | -57.10 L | -3.04 Cr |
| Diluted EPS | - | 1.41 | -1.80 | -0.46 | -2.44 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 125.99 Cr | 127.28 Cr | 125.42 Cr | 115.46 Cr |
| Current Assets | - | 60.20 Cr | 60.01 Cr | 53.44 Cr | 47.02 Cr |
| Cash & Equivalents | - | 1.11 Cr | 32.14 L | 41.20 L | 50.31 L |
| Inventory | - | 7.07 Cr | 5.74 Cr | 3.20 Cr | 2.94 Cr |
| Receivables | - | 8.46 Cr | 10.82 Cr | 8.79 Cr | 6.92 Cr |
| Total Liabilities | - | 7.42 Cr | 6.30 Cr | 4.15 Cr | 3.85 Cr |
| Current Liabilities | - | 6.39 Cr | 5.26 Cr | 3.10 Cr | 2.71 Cr |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 0 | 0 | 0 | 0 |
| Total Equity | - | 118.57 Cr | 120.98 Cr | 121.28 Cr | 111.61 Cr |
| Shares Outstanding | - | 1.25 Cr | 1.25 Cr | 1.25 Cr | 1.25 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -6.08 Cr | 6.94 Cr | 5.07 Cr | -7.02 Cr |
| Investing Cash Flow | - | -2.56 Cr | -7.73 Cr | -4.98 Cr | 7.11 Cr |
| Financing Cash Flow | - | 0 | 0 | 0 | 0 |
| Capital Expenditure | - | -1.16 Cr | -34.58 L | -32.59 L | -84.64 L |
| Free Cash Flow | - | -7.24 Cr | 6.59 Cr | 4.74 Cr | -7.87 Cr |
| Net Change in Cash | - | -8.64 Cr | -79.21 L | 9.06 L | 9.11 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 48.3% | 64.2% | 58.0% | 54.5% |
| Operating Margin % | - | 5.8% | -6.5% | -14.0% | -90.5% |
| Net Margin % | - | 3.6% | -8.4% | -2.3% | -24.5% |
| ROE % | - | 1.5% | -1.9% | -0.5% | -2.7% |
| ROCE % | - | 2.4% | -1.4% | -2.9% | -10.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MEDICAPQ
MEDICAPQ Stock Price and Chart — NSE:MEDICAPQ - TradingView
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9HeTdnZE5ZYTZtUloxOGFKVlJ5NVZIZGszelFEdGpQem9XN1QyZFlQS2VVMDVQZGF0WVhRRzNfcGJ0cnJ6RDk3T2UtaWNvYnVzSXI4MzhPZzFoQ18tbnc?oc=5" target="_blank">MEDICAPQ Stock Price and Chart — NSE:MED…
Technical Analysis of Medi-Caps Ltd. (NSE:MEDICAPQ) - TradingView
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1vQWJZdGlaTDNBUGY5U1VLRXhEdm94YWpjWkF2OWo2YzFTRmZKUWhfV0JRNjcya3BHOGVDd2Z0NWFJbE5weUFsUzJ3RC1qQ1diYlFJcmpKYnl3RVFIZnVxQ2tWY3NxajFUTG13Nw?oc=5" target="_blank">Technical Analysis of…
ANG Stock Price and Chart — BSE:ANG - TradingView
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBINGo4OG1TTVJ3RWFCbnZCZUxBQmRkaldNeDgtSnNLLVhOUFZadk90WHFWZl9uREpzcFVjZHZLZUVpOHJyNm04Z3hsczlCeUNlUlQtRjc4Yw?oc=5" target="_blank">ANG Stock Price and Chart — BSE:ANG</a> &nbs…
BIBCL Stock Price and Chart — BSE:BIBCL - TradingView
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE9PNTg1amVQSDhSQUVsNjJPOVJPdjhoaVRTbzNsd3lWN2ZtTVBqLWhNempiTGZINFc5cEtWS1ZteGEtNWVybXJEaHdsbmVuOTFQQWVOZmNUcG51QQ?oc=5" target="_blank">BIBCL Stock Price and Chart — BSE:BIBCL</a>&n…
BIOFILCHEM Stock Price and Chart — NSE:BIOFILCHEM - TradingView
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFA2TFFOd2gxQmRiSzJBWXgwb3hzZ0w3Uk5iUVNHaVFudFdfYnkwd0lMaUdiXzdUQmdJUWhBY29UUDlkQWNjOWZQUFpnem9OcTQzTTFVNjFSVlc5TDFzWENNbg?oc=5" target="_blank">BIOFILCHEM Stock Price and Chart — NS…
MEDICAPQ — Frequently Asked Questions
What is the current share price of Medi-Caps Limited (MEDICAPQ)?
As of 2026-10-24 04:55 IST, Medi-Caps Limited (MEDICAPQ) trades at ₹25.00 on NSE. Its 52-week range is ₹23.56 to ₹35.22.
What is the market capitalisation of MEDICAPQ?
Medi-Caps Limited (MEDICAPQ) has a market capitalisation of ₹31.17 Cr on NSE.
What is the P/E ratio of MEDICAPQ?
MEDICAPQ trades at a trailing price-to-earnings (P/E) ratio of -17.48. The industry average P/E is 21.54. Its price-to-book (P/B) ratio is 0.28.
What is the return on equity (ROE) of MEDICAPQ?
MEDICAPQ has a return on equity (ROE) of -2.72%. Its return on capital employed (ROCE) is -9.95%.
Is MEDICAPQ a good stock to buy?
This page provides a data-driven analysis of Medi-Caps Limited (MEDICAPQ), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.